Trial Profile
A comparison of budesonide/formoterol [Symbicort] Turbuhaler 160/4.5 microg 2 inhalations BID [twice daily] plus as needed to budesonide [Pulmicort] Turbuhaler 320 microg 2 inhalations BID plus terbutaline [Bricanyl] Turbuhaler 0.4 mg as needed for the prevention of asthma relapse.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Feb 2011
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide; Terbutaline
- Indications Asthma
- Focus Therapeutic Use
- Acronyms PARADE
- Sponsors AstraZeneca
- 01 Jan 2008 Status changed from in progress to completed.
- 07 Oct 2006 New trial record.